Treatment of Severe Multicentric Reticulohistiocytosis With Upadacitinib

JAMA Dermatol. 2021 Jun 1;157(6):735-737. doi: 10.1001/jamadermatol.2021.0996.
No abstract available

MeSH terms

  • Arthritis*
  • Heterocyclic Compounds, 3-Ring
  • Histiocytosis, Non-Langerhans-Cell* / diagnosis
  • Histiocytosis, Non-Langerhans-Cell* / drug therapy
  • Humans
  • Hyperplasia

Substances

  • Heterocyclic Compounds, 3-Ring
  • upadacitinib